Zanubrutinib
Update Venetoclax in CLL
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
Patient Power
UpToDate
ASH: COVID-19 Resources for Managing Blood Cancers
NCCN Guidelines for Patients for CLL